Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Valeant Pharmaceuticals International (Swiss & Puerto Rican plants)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

220 acre campus of drugs production facilities. The facility contains of Swiss and Puerto Rican plants that produces and distributes drugs in tablet and liquid forms.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Legacy Pharmaceuticals International

Valeant Pharmaceuticals International (Swiss & Puerto Rican plants) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Valeant Pharmaceuticals International (Swiss & Puerto Rican plants)‘s full profile, request access.

Request full access to PitchBook

Valeant Pharmaceuticals International (Swiss & Puerto Rican plants) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Valeant Pharmaceuticals International (Swiss & Puerto Rican plants)‘s full profile, request access.

Request full access to PitchBook